MedPage Today on MSN4d
Have the New Pulmonary Hypertension Drugs Changed the Game?After the FDA approved both combination macitentan/tadalafil (Opsynvi) and the biologic therapy sotatercept (Winrevair) for ...
Hosted on MSN37m
UK MHRA approves MSD’s pulmonary arterial hypertension therapyMSD has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for sotatercept, marketed as ...
High-dose nonsteroidal anti-inflammatory drug use among patients with axial spondyloarthritis (axSpA) may not increase the ...
Nov. 21, 2024 — Scientists have discovered how long-term treatment of high blood pressure with commonly prescribed drugs can destroy the kidney's ability to filter and purify blood. The finding ...
PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...
The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...
Shares in Idorsia slumped after the company said it failed to sell the rights to its hypertension treatment and that is considering alternatives that would allow it to keep operating. Shares in ...
Dietary Changes: Reduce sodium intake by avoiding processed foods. Instead, opt for potassium-rich options like bananas, ...
People who have high blood pressure prefer taking medicines as part of treatment; however, medication is not useful in the long run.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results